Related Experiment Videos
Malignant eyelid tumours in Taiwan.
1Department of Ophthamology, Far Eastern Memorial Hospital, Taipei, Taiwan.
Eye (London, England)
|March 18, 2003
Summary
This study analyzed 127 eyelid cancers in Taiwan, finding basal cell carcinoma most common. Sebaceous gland carcinoma, though less frequent, showed higher recurrence and mortality rates, necessitating aggressive treatment.
Area of Science:
- Ophthalmology
- Oncology
- Dermatology
Background:
- Eyelid cancers represent a significant clinical challenge.
- Understanding the epidemiology and characteristics of eyelid malignancies is crucial for effective patient management.
Purpose of the Study:
- To delineate the clinical features of eyelid cancers in the Taiwanese population.
- To compare the prognoses of different types of eyelid malignancies.
Main Methods:
- Retrospective analysis of 127 histologically confirmed eyelid cancer cases from 1980-2000.
- Review of clinical data, including tumor location, type, treatment, and follow-up outcomes.
- Statistical comparison of recurrence, metastasis, and mortality rates between basal cell carcinoma and sebaceous gland carcinoma.
Main Results:
- Basal cell carcinoma (62.2%) was the most prevalent eyelid cancer, followed by sebaceous gland carcinoma (23.6%).
- Tumors occurred more frequently on the lower eyelid (37.0%) than the upper eyelid (33.9%).
- Five-year rates for recurrence, metastasis, and mortality were 15.2%, 11.7%, and 7.3%, respectively, with significantly higher rates for sebaceous gland carcinoma compared to basal cell carcinoma.
Conclusions:
- Basal cell carcinoma is the most common eyelid cancer in Taiwan, but sebaceous gland carcinoma also warrants attention due to its aggressive nature.
- Sebaceous gland carcinoma presents a poorer prognosis and higher mortality risk than basal cell carcinoma, demanding more aggressive therapeutic strategies.
- Long-term monitoring is essential for patients treated for malignant eyelid tumors to detect and manage recurrences or metastases effectively.